Neurocognitive disorders

There are 210 papers on neurocognitive disorders in aging research: 9 trials and 108 observational studies in people, 4 in animals, 78 reviews.

Disease

210 papers study it665 more mention it43 findings

MeSH

15 new papers in 30 daysSee all 875 papers on neurocognitive disorders

At a glance

Neurocognitive disorders are linked with higher mortality and functional decline in human observational studies. A human trial reports that cognitive training combined with exercise lowers their risk after total hip replacement. Observational studies link older age, hypertension, depression, and sleep disorders with higher risk; physical frailty without cognitive impairment shows no clear link.

43 findings in 31 papers from 2016 to 2026, 5 of them since April 2026

“The incidence of NCD in the exercise group (10%, 5/50) was significantly lower than that in the control group (27.8%, 10/36) (P=0.032).”
Short-term perioperative cognitive therapy combined with rehabilitation exercise reduces the incidence of neurocognitive disorder in elderly patients: a randomized controlled trialMinerva anestesiologica2022doi:10.23736/s0375-9393.21.15877-8
  • Human trial9
  • Humans108
  • Animals4
  • In silico2

Effects

4

Brain age

upin humans1

1 study
  1. Neurocognitive disorders increase brain age in humans (neurocognitive disorders) (Cohen's d = 3.27, 95 % CI 2.31-4.24, p < 0.05).

    “neurocognitive disorders (Cohen's d = 3.27, 95 % CI 2.31-4.24, p < 0.05)”

    Reviewneurocognitive disorders

    Neuroimaging-derived brain age as a new promising biomarker in mental disorders

    Neuroscience and biobehavioral reviews

More on Brain age

Visuospatial performance

downin humans1

1 study
  1. Neurocognitive disorders are linked with lower visuospatial performance in humans (clinical group vs controls).

    “The clinical group scored significantly lower than the control group, highlighting the impact of cognitive impairment on visuospatial performance.”

    Humansclinical group vs controlsn = 113

    Judgment Line Orientation Test: a proposal for an abbreviated version for the Brazilian population

    AAIC 2025 abstract

Cognitive function

downin humans1

1 study
  1. Neurocognitive disorders are linked with worse cognitive function in humans (primary neurocognitive disorder vs no cognitive impairment or primary psychiatric disorder).

    “The individuals with a primary neurocognitive disorder performed significantly poorer on most of the recognition scores compared to those with no cognitive impairment”

    Humansprimary neurocognitive disorder vs no cognitive impairment or primary psychiatric disorder

    Recognition Subtests for Form B of the Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Validation

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

Fall severity

no changein humans1

1 study
  1. Neurocognitive disorders were not clearly linked with fall severity in humans (patients admitted for fall in a geriatric hospital).

    “We did not find a statistically significant association between the severity of neurocognitive disorders evaluated with the MMSE and the serious falls.”

    Humanspatients admitted for fall in a geriatric hospitaln = 100

    Association between the severity of neurocognitive disorders and the seriousness of falls in the elderly

    Geriatrie et psychologie neuropsychiatrie du vieillissement

Upstream

1

Physical frailty

no changein humans1

1 study
  1. Physical frailty was not clearly linked with neurocognitive disorders in humans (without cognitive impairment).

    “prefrail or frail old adults without cognitive impairment had no increased risk of incident NCD”

    Humanswithout cognitive impairment

    Physical Frailty, Cognitive Impairment, and the Risk of Neurocognitive Disorder in the Singapore Longitudinal Ageing Studies

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Physical frailty

Associations

35

Hypertension

upin humans2

2 studies
  1. Hypertension is linked with a higher risk of neurocognitive disorders in humans.

    “Among younger adults, lower educational levels, a native language other than Spanish, hypertension, and depression were risk factors for NCD”

    Humans

    Risk factors associated with neurocognitive disorder and depression among adults from an urban‐marginalized area of Lima, Peru

    AAIC 2025 abstract

  2. Hypertension is linked with a higher risk of neurocognitive disorders in humans (urban-marginalized cohort in Lima, Peru).

    “Risk factors for MCI and NCD included lower education, hypertension, and non-Spanish native language”

    Humansurban-marginalized cohort in Lima, Peruboth (71% female)sn = 1,064

    Neurocognitive disorders, depression, and associated factors in younger and older adults from an urban-marginalized area of Peru

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Hypertension

Age

upin humans2OR 1.07

2 studies
  1. Age predicts neurocognitive disorders in humans (OR 1.07 (95% CI 1.02-1.13), p = 0.01).

    “Age (odds ratio (95%CI) 1.07 (1.02-1.13); p = 0.01) and baseline cognitive impairment (odds ratio (95%CI) 2.1 (1.06-4.15); p = 0.03) were significant predictors of neurocognitive disorder 5 years after surgery.”

    Humans5 years

    Prevalence of neurocognitive disorders 5 years after elective orthopaedic surgery

    Anaesthesia

  2. Age is linked with a higher risk of neurocognitive disorders in humans.

    “the older the age, the risk of developing neurocognitive disorders would increase”

    Humansn = 257

    Prevalence of neurocognitive disorders in a rural area of Argentina

    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)

Mortality

upin humans2HR 1.24

2 studies
  1. Neurocognitive disorders are linked with a higher risk of mortality in humans (aHR 1.54, 95% CI 1.19-1.98, p < 0.001).

    “adjusted hazard ratio (aHR) [95% confidence interval (CI)] for a major NCD = 1.54 [1.19-1.98] (p < 0.001)”

    Humanssolid cancer, adjusted for geriatric factors, cancer type, metastatic status, and treatment strategy12 monthsn = 2,784

    Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study

    The journal of nutrition, health & aging

  2. Neurocognitive disorders are linked with a higher risk of mortality in humans (HR 1.24, 95% CI 1.23-1.25, p<0.0001).

    “patients with a neurocognitive disorder had higher 30-day (hazard ratio 1·24 [95% CI 1·23-1·25]; p<0·0001), 90-day (1·25 [1·24-1·26]; p<0·0001), and 365-day mortality”

    Humansn = 5,263,264

    Association of neurocognitive disorders with morbidity and mortality in older adults undergoing major surgery in the USA: a retrospective, population-based, cohort study

    The lancet. Healthy longevity

Hybrid CNN-LSTM deep learning classifier

upin silico1

1 study
  1. hybrid CNN-LSTM deep learning classifier predicts neurocognitive disorders in silico (AUC-ROC 0.971, accuracy 95.1%).

    “yielding an accuracy of 95.1%, precision of 93.4%, recall of 94.2%, and F1-score of 93.8%, with an AUC-ROC of 0.971.”

    In silico

    AI-Driven Intelligent IoT Frameworks for Early Neurocognitive Disorder Detection and Assistive Intervention

    Advances in computational intelligence and robotics book series

Machine-learning

upin silico1

1 study
  1. machine-learning predicts neurocognitive disorders in silico (edge computing XAI model).

    “Performance evaluation by common metrics shows the efficiency of the suggested approach.”

    In silicoedge computing XAI model

    Edge-Ready Explainable AI for Early Detection of Neurocognitive Decline

    Advances in computational intelligence and robotics book series

CD4 lymphocyte count below 500 cells/μL

upin humans1

1 study
  1. CD4 lymphocyte count below 500 cells/μL is associated with neurocognitive disorders in humans (HIV infection with undetectable viral load while receiving antiretroviral therapy).

    “with a CD4 lymphocyte count of less than 500 cells/μL, the odds of developing neurocognitive disorders (p=0.001) and liver cirrhosis (p=0.023) were significantly higher.”

    HumansHIV infection with undetectable viral load while receiving antiretroviral therapy

    Noninfectious comorbid diseases in HIV-infected patients receiving virologically effective antiretroviral therapy

    Клиническая инфектология и паразитология

More on CD4 lymphocyte count below 500 cells/μL

Physical restraint

upin humans1

1 study
  1. Neurocognitive disorders are linked with a higher risk of physical restraint in humans (difference 11.2%, 3.0-19.1).

    “restraint episodes (difference 11.2%, 3.0-19.1; P < .001) compared to patients without neurocognitive disorders.”

    Humansn = 334

    Emergency Department Boarding for Psychiatric Hospitalization in Older Adults: Placement Challenges and Associated Risks

    The western journal of emergency medicine

Functional decline

upin humans1

1 study
  1. Neurocognitive disorders are linked with a higher risk of functional decline in humans (difference 17.1%, 95% CI, 7.3-26.4).

    “Patients with neurocognitive disorders (157/334, 47.0%) had higher rates of functional decline (difference 17.1%, 95% CI, 7.3-26.4; P < .001)”

    Humansn = 334

    Emergency Department Boarding for Psychiatric Hospitalization in Older Adults: Placement Challenges and Associated Risks

    The western journal of emergency medicine

Hong Kong population aged 60 years or above

upin humans1

1 study
  1. Hong Kong population aged 60 years or above is associated with neurocognitive disorders in humans (community-dwelling and residential care home residents) (21.8% mild NCD, 9.7% major NCD).

    “The age- and gender-adjusted prevalences of mild and major NCD were 21.8% and 9.7%, respectively, among adults aged 60 years or above in Hong Kong.”

    Humanscommunity-dwelling and residential care home residentsn = 4,871

    Prevalence of mild and major neurocognitive disorders in community and residential care homes in Hong Kong: considerations for multidimensional risk factor evaluation and intervention in primary care

    Hong Kong medical journal = Xianggang yi xue za zhi

UCH-L1

upin humans1

1 study
  1. Neurocognitive disorders are associated with UCH-L1 in humans.

    “Post‐operatively, people with NCD had significantly higher levels of UHCL‐1, while non‐NCD patients had higher anti‐inflammatory IL‐10.”

    Human trial3 monthsn = 44

    The Potential of Using ADRD‐related Biomarkers to Predict and Diagnose Perioperative Neurocognitive Disorders in Elderly Patients Undergoing Surgery

    AAIC 2025 abstract

More on UCH-L1

IL-4

downin humans1

1 study
  1. Neurocognitive disorders are associated with IL-4 in humans.

    “Pre‐surgical biomarker levels did not differ significantly between groups, except in anti‐inflammatory IL‐4 levels which were lower in those who developed NCD.”

    Human trial3 monthsn = 44

    The Potential of Using ADRD‐related Biomarkers to Predict and Diagnose Perioperative Neurocognitive Disorders in Elderly Patients Undergoing Surgery

    AAIC 2025 abstract

More on IL-4

Cognitive training + exercise

downin humans1

1 study
  1. Cognitive training + exercise lowers the risk of neurocognitive disorders in humans after total hip joint replacement surgery (10% (5/50) vs 27.8% (10/36), P=0.032).

    “The incidence of NCD in the exercise group (10%, 5/50) was significantly lower than that in the control group (27.8%, 10/36) (P=0.032).”

    Human trialafter total hip joint replacement surgeryn = 86

    Short-term perioperative cognitive therapy combined with rehabilitation exercise reduces the incidence of neurocognitive disorder in elderly patients: a randomized controlled trial

    Minerva anestesiologica

More on Cognitive training + exercise

All 35

Trial sponsors

Funding

20 grants since 2017

National Institute on Aging$18.7MNational Institute of General Medical Sciences$2.3MUS Department of Veterans Affairs

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 44Jan 2026: 27Feb 2026: 24Mar 2026: 15Apr 2026: 16May 2026: 15Jun 2026: 17Jul 2026: 24Aug 2026: 11Sep 2026: 24Oct 2026: 18Nov 2026: 6241 papers in 12 months

See all 875 papers on neurocognitive disorders